May 2022
Events
Five alternative trusts for income investors
Slides and audio from our event last week, featuring five trust managers discussing different strategies to deliver income for shareholders in challenging market conditions...
31 May
31 May
Replay
Slides and Audio: International Biotechnology
Download the presentation and listen to the audio from our 'Alternatives for income investors' virtual week from 25 May...
27 May
27 May
April 2022
Strategy
The inevitabilities: death and taxes
Biotech has had a rough ride lately but, as the world gets older and richer, our analysts think long-term secular growth is inevitable…
14 Apr
14 Apr
Events
Five trusts to diversify your portfolio income
Join us next week for one live webinar with a different manager every day of the week – including the chance to ask questions - focused on different solutions for those seeking a decent income…
29 Apr
29 Apr
March 2022
Head to head
You say tomato…
Do it yourself or put it into a global fund and leave it to the experts - our analyst debate the merits of each approach...
30 Mar
30 Mar
Features
A true all-rounder
IBT offers growth, income and diversification as well as a positive impact for society itself…
30 Mar
30 Mar
Fund Research
International Biotechnology
IBT’s managers appear confident that valuations are increasingly attractive…
30 Mar
30 Mar
December 2021
Features
And now for something completely different
We take a look at a trust which could add significant diversification to income investors’ portfolios…
20 Dec
20 Dec
Features
Further cancer breakthroughs hinge on biotech investment
By Marek Poszepczynski and Ailsa Craig, co-investment managers of the International Biotechnology Trust...
08 Dec
08 Dec
March 2021
Events
Spring Conference '21
Audio and presentations from 21 of the UK’s leading investment trust managers…
10 Mar
10 Mar
Replay
Slides and Audio: International Biotechnology Trust
Download the presentation and listen to the audio from our 'Ideas for your ISA' Spring Conference on 03 March...
08 Mar
08 Mar
Features
Is biotechnology M&A the big opportunity post-vaccine?
After a vintage year in which healthcare stocks were at the forefront of addressing the coronavirus pandemic, a wave of M&A in the sector promises opportunities for investors…
26 Mar
26 Mar
August 2020
Events
Alternatives for income investors
In a world where dividend are under unprecedented pressure, our income focused online event in September should provide serious food for thought…
20 Aug
20 Aug
Head to head
Trump v. Biden
Two of our analysts debate who will win the US election and what that means for markets…
26 Aug
26 Aug
Features
Income, growth, diversification: A compelling combination
This trust offers a blend of characteristics which might appeal to many investors...
21 Aug
21 Aug
Features
M&A and unlisted companies: Two powerful themes behind International Biotechnology Trust
The acquisition of smaller biotech companies by their larger counterparts has been a tailwind for investors in this high-octane sector...
06 Aug
06 Aug
July 2020
Strategy
The next big thing: two mega-trends that everyone should own
Tech seems to beat every other sector hands down – in both up and down markets – but nothing lasts forever. Where else should investors be looking for secular growth themes?
09 Jul
09 Jul
Features
Biotech: The high stakes investment theme where expertise is everything
We meet the team of doctors and medical scientists behind International Biotechnology Trust...
20 Jul
20 Jul
Fund Research
International Biotechnology
IBT offers a differentiated exposure to a secular growth theme complemented by a solid yield…
08 Jul
08 Jul